Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.310 |
None |
1.000 |
2 |
|
2014 |
2019 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.310 |
None |
1.000 |
2 |
|
2003 |
2012 |
Myopathy
|
group |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
634
|
166
|
0.310 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.300 |
None |
0.971 |
35 |
4
|
2000 |
2020 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.300 |
None |
1.000 |
23 |
1
|
2003 |
2019 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
3 |
|
2003 |
2013 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
3 |
|
2003 |
2013 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.300 |
None |
1.000 |
3 |
|
2003 |
2013 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
2 |
|
2005 |
2011 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.300 |
None |
1.000 |
2 |
|
2005 |
2011 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hepatomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Finding
|
523
|
30
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Animal Mammary Neoplasms
|
phenotype |
Neoplasms; Animal Diseases
|
Neoplastic Process
|
147
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Benign Neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
371
|
7
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Crohn's disease of large bowel
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
96
|
1
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Eczema, Infantile
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
36
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Experimental Autoimmune Encephalomyelitis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Experimental Model of Disease
|
97
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Regional enteritis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
46
|
15
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Proteinuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
239
|
20
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Crohn's disease of the ileum
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
55
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Fasting Hypoglycemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
39
|
1
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Reactive hypoglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
23
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Myocardial Reperfusion Injury
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
226
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |